Weight loss, diabetes drugs propel Eli Lilly to largely better-than-expected forecast for 2024

Eli Lilly rode soaring demand for diabetes and weight-loss treatments to a better-than-expected finish in 2023, and the drugmaker expects momentum to carry into the new year.

Related Keywords

North Carolina ,United States ,Eli Lilly ,David Ricks ,Drug Administration ,Wall Street ,Indianapolis Based Eli Lilly ,